Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos N Liberopoulos

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|February 10, 2009
Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant?Moses Elisaf, Evangelos N Liberopoulos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 26, 2005
Greece: one of the thirty top-performing countries in all scientific fields?Evangelos N Liberopoulos, Dimitri P Mikhailidis
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 16, 2022
A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery DiseaseTheocharis Koufakis, Evangelos N Liberopoulos, Kalliopi Kotsa
Archives of Medical Science : AMS|February 1, 2012
Life-threatening hypophosphataemia in a cirrhotic patient with jaundiceElisavet Moutzouri, Evangelos N Liberopoulos, Moses Elisaf
Current Vascular Pharmacology|July 15, 2010
HypocholesterolemiaElisavet Moutzouri, Moses Elisaf, Evangelos N Liberopoulos
Current Vascular Pharmacology|February 15, 2011
What restricts the clinical use of nicotinic acid?Anastazia Kei, Evangelos N Liberopoulos, Moses S Elisaf
Journal of the Cardiometabolic Syndrome|February 28, 2009
Statin pleiotropy against renal injuryMichael S Kostapanos, Evangelos N Liberopoulos, Moses S Elisaf
The International Journal of Lower Extremity Wounds|November 9, 2019
Canagliflozin and Amputation Risk: Evidence So FarEleni Papadokostaki, Evangelos Rizos, Stelios Tigas, et al.
European Journal of Internal Medicine|July 20, 2011
Novel roles of vitamin D in disease: what is new in 2011?Stefania Makariou, Evangelos N Liberopoulos, Moses Elisaf, et al.
Therapeutic Advances in Endocrinology and Metabolism|February 14, 2015
Dapagliflozin in patients with type 2 diabetes mellitusTheodosios D Filippatos, Evangelos N Liberopoulos, Moses S Elisaf
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|February 10, 2009
Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant?Moses Elisaf, Evangelos N Liberopoulos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 26, 2005
Greece: one of the thirty top-performing countries in all scientific fields?Evangelos N Liberopoulos, Dimitri P Mikhailidis
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 16, 2022
A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery DiseaseTheocharis Koufakis, Evangelos N Liberopoulos, Kalliopi Kotsa
Archives of Medical Science : AMS|February 1, 2012
Life-threatening hypophosphataemia in a cirrhotic patient with jaundiceElisavet Moutzouri, Evangelos N Liberopoulos, Moses Elisaf
Current Vascular Pharmacology|July 15, 2010
HypocholesterolemiaElisavet Moutzouri, Moses Elisaf, Evangelos N Liberopoulos
Current Vascular Pharmacology|February 15, 2011
What restricts the clinical use of nicotinic acid?Anastazia Kei, Evangelos N Liberopoulos, Moses S Elisaf
Journal of the Cardiometabolic Syndrome|February 28, 2009
Statin pleiotropy against renal injuryMichael S Kostapanos, Evangelos N Liberopoulos, Moses S Elisaf
The International Journal of Lower Extremity Wounds|November 9, 2019
Canagliflozin and Amputation Risk: Evidence So FarEleni Papadokostaki, Evangelos Rizos, Stelios Tigas, et al.
European Journal of Internal Medicine|July 20, 2011
Novel roles of vitamin D in disease: what is new in 2011?Stefania Makariou, Evangelos N Liberopoulos, Moses Elisaf, et al.
Therapeutic Advances in Endocrinology and Metabolism|February 14, 2015
Dapagliflozin in patients with type 2 diabetes mellitusTheodosios D Filippatos, Evangelos N Liberopoulos, Moses S Elisaf
Pageof 9